Neuropace Inc (NPCE)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Finanzdaten der Neuropace Inc-Aktie (NPCE)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	2.80% 26.59	27.35	23.52	22.52	21.47
Cost Of Revenue	2.85% 6.01	6.186	5.388	5.182	5.278
Gross Profit	2.79% 20.58	21.17	18.13	17.34	16.19
Operating Expenses	5.99% 22.34	23.77	24.96	22.49	19.84
Benefits Costs and Expenses	-	-	-	-	-
Costs And Expenses	5.34% 28.36	29.95	30.34	27.67	25.12
Operating Income/Loss	32.04% -1.767	-2.60	-6.824	-5.147	-3.653
Income/Loss From Continuing Operations Before Tax	2.80% 26.59	27.35	-8.651	-6.589	21.47
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	21.94% -2.729	-3.496	-8.651	-6.589	-5.25
Net Income/Loss	21.94% -2.729	-3.496	-8.651	-6.589	-5.25
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.33% 0.2235	33.13	32.86	31.48	0.2632
Diluted Average Shares	99.33% 0.2235	33.13	32.86	31.48	0.2632
Basic Earnings Per Share	27.27% -0.08	-0.11	-0.26	-0.21	-0.17
Diluted Earnings Per Share	27.27% -0.08	-0.11	-0.26	-0.21	-0.17
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

ZBH

$93.20

0.66%

STE

$214.57

1.05%

DXCM

$64.24

1.56%

PHG

$27.79

1.66%

GEHC

$70.77

0.63%

$81.81

3.31%